Silence Therapeutics (SLN) Revenue (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,141.18% |
| Dec 31, 2025 | -78.62% |
| Sep 30, 2025 | -20.50% |
| Jun 30, 2025 | 40.85% |
| Mar 31, 2025 | -99.44% |
| Dec 31, 2024 | 1,589.25% |
| Sep 30, 2024 | 98.15% |
| Jun 30, 2024 | -95.18% |
| Mar 31, 2024 | 502.61% |
| Dec 31, 2023 | -26.49% |
| Sep 30, 2023 | -68.89% |
| Jun 30, 2023 | -17.60% |
| Mar 31, 2023 | 147.36% |
| Dec 31, 2022 | 40.68% |
| Sep 30, 2022 | -13.40% |
| Jun 30, 2022 | -40.25% |
| Mar 31, 2022 | 66.84% |
| Dec 31, 2021 | 5.78% |
| Sep 30, 2021 | 15.25% |
| Jun 30, 2021 | 86,981.41% |
| Mar 31, 2021 | -99.94% |
| Dec 31, 2020 | 281,738.15% |